サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1416437

体外受精レポート：2030年までの動向、予測、競合分析

In Vitro Fertilization Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.12円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

体外受精レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

体外受精の動向と予測

世界の体外受精市場は、2024年から2030年までのCAGRが5.2%で、2030年までに推定334億米ドルに達すると予想されています。この市場の主な促進要因は、不妊症および業界で利用可能なさまざまな治療法に対する意識の高まり、ライフスタイルの変化による不妊率の上昇、およびヘルスケア分野での着床前遺伝子スクリーニングまたは診断の利用増加です。世界の体外受精市場の将来は、不妊治療クリニックや病院市場での機会があり、有望に見えます。

体外受精市場に関する洞察

Lucintelは、凍結非ドナーは新鮮な非ドナーと比較して費用対効果が高く、処置の侵襲性が低いため、予測期間を通じて引き続き最大のセグメントになると予測しています。

この市場では、ART治療の需要の高まり、不妊治療クリニックの数の増加、新しい不妊治療クリニックの設立に対する政府の取り組みの高まりにより、不妊治療クリニックが予測期間を通じて引き続き大きなセグメントとなるでしょう。

アジア太平洋地域は、中国やインドなどの経済圏における人口ベースの多さ、体外受精に対する意識の高まり、この地域での不妊人口の増加により、予測期間中に最も高い成長を遂げると予想されます。

よくある質問

Q.1体外受精の市場規模はどれくらいですか：

A1.世界の体外受精市場は、2030年までに推定334億米ドルに達すると予想されています。

Q.2体外受精市場の成長予測は：

A2.世界の体外受精市場は、2024年から2030年にかけて5.2%のCAGRで成長すると予想されています。

Q.3体外受精市場の成長に影響を与える主な要因は何ですか：

A3.この市場の主な促進要因は、不妊症および業界で利用可能なさまざまな治療法に対する意識の高まり、ライフスタイルの変化による不妊率の上昇、およびヘルスケア分野での着床前遺伝子スクリーニングまたは診断の利用増加です。

Q4.市場の主要セグメントは：

A4.体外受精市場の将来は、不妊治療クリニックや病院市場での機会があり、有望に見えます。

Q5.市場の主要企業は：

A5.主要な体外受精会社は次のとおりです。

  • CooperSurgical
  • Vitrolife
  • Cook Medical
  • Irvine Scientific
  • Thermo Fisher Scientific
  • EMD Sereno
  • Genea Limited
  • Esco Micro
  • IVFtech
  • The Baker Company

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、凍結非ドナーは新鮮な非ドナーと比較して費用対効果が高く、処置の侵襲性が低いため、予測期間を通じて引き続き最大のセグメントになると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.アジア太平洋地域は、中国やインドなどの経済圏における人口ベースの多さ、体外受精に対する意識の高まり、この地域での不妊人口の増加により、予測期間中に最も高い成長を遂げると予想されます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の体外受精市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の体外受精市場動向（2018～2023年）と予測（2024～2030年）
  • 製品別の世界の体外受精市場
    • 医療機器
    • 培養基
    • 使い捨てデバイス
  • 種類別の世界の体外受精市場
    • 新たな非ドナー
    • 凍結された非ドナー
    • 新たなドナー
    • 凍結ドナー
  • 最終用途産業別の世界の体外受精市場
    • 不妊クリニック
    • 病院など

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の体外受精市場
  • 北米の体外受精市場
  • 欧州の体外受精市場
  • アジア太平洋の体外受精市場
  • その他地域の体外受精市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析
  • 成長機会分析
    • 製品別の世界の体外受精市場の成長機会
    • 種類別の世界の体外受精市場の成長機会
    • 最終用途産業別の世界の体外受精市場の成長機会
    • 地域別の世界の体外受精市場の成長機会
  • 世界の体外受精市場の新たな動向
  • 戦略的分析
    • 世界の体外受精市場の能力拡大
    • 世界の体外受精市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • CooperSurgical
  • Vitrolife
  • Cook Medical
  • Irvine Scientific
  • Thermo Fisher Scientific
  • EMD Sereno
  • Genea Limited
  • Esco Micro
  • IVFtech
  • The Baker Company
目次

In Vitro Fertilization Trends and Forecast

The future of the global in vitro fertilization market looks promising with opportunities in the fertility clinic and hospital markets. The global in vitro fertilization market is expected to reach an estimated $33.4 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are growing awareness of infertility and various therapies available in the industry, rise in the infertility rates as a result of lifestyle changes along with increasing usage of preimplantation genetic screening or diagnosis in the healthcare sector.

A more than 150-page report is developed to help in your business decisions.

In Vitro Fertilization by Segment

The study includes a forecast for the global in vitro fertilization by product, type, end use industry, and region

In Vitro Fertilization Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Capital Equipment
  • Culture Media
  • Disposable Devices

In Vitro Fertilization Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Fresh Non-Donors
  • Frozen Non-Donors
  • Fresh Donors
  • Frozen Donors

In Vitro Fertilization Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Fertility Clinics
  • Hospitals & others

In Vitro Fertilization Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of In Vitro Fertilization Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in vitro fertilization companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in vitro fertilization companies profiled in this report include-

  • Coopersurgical
  • Vitrolife
  • Cook Medical
  • Irvine Scientific
  • Thermo Fisher Scientific
  • Emd Sereno
  • Genea Limited
  • Esco Micro
  • Ivftech
  • The Baker Company

In Vitro Fertilization Market Insights

Lucintel forecast that frozen non-donor will remain the largest segment over the forecast period due to its cost-effectiveness as compared to fresh non-donor and less-invasive nature of the procedure.

Within this market, fertility clinics will remain the larger segment over the forecast period due to growing demand for ART treatments, increasing number of fertility clinics, and rising government intiatives to set up new fertility clinics.

APAC will witness the highest growth over the forecast period due to large number of population base in economies like China and India, growing awareness of IVF treatment, and rising number of infertile people in the region.

Features of the Global In Vitro Fertilization Market

Market Size Estimates: In vitro fertilization market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: In vitro fertilization market size by various segments, such as by product, type, end use industry, and region in terms of value ($B).

Regional Analysis: In vitro fertilization market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, end use industries, and regions for the in vitro fertilization market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in vitro fertilization market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the in vitro fertilization market size?

Answer: The global in vitro fertilization market is expected to reach an estimated $33.4 billion by 2030.

Q.2 What is the growth forecast for in vitro fertilization market?

Answer: The global in vitro fertilization market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the in vitro fertilization market?

Answer: The major drivers for this market are growing awareness of infertility and various therapies available in the industry, rise in the infertility rates as a result of lifestyle changes along with increasing usage of preimplantation genetic screening or diagnosis in the healthcare sector.

Q4. What are the major segments for in vitro fertilization market?

Answer: The future of the in vitro fertilization market looks promising with opportunities in the fertility clinic and hospital markets.

Q5. Who are the key vitro fertilization market companies?

Answer: Some of the key in vitro fertilization companies are as follows:

  • CooperSurgical
  • Vitrolife
  • Cook Medical
  • Irvine Scientific
  • Thermo Fisher Scientific
  • EMD Sereno
  • Genea Limited
  • Esco Micro
  • IVFtech
  • The Baker Company

Q6. Which in vitro fertilization market segment will be the largest in future?

Answer: Lucintel forecast that frozen non-donor will remain the largest segment over the forecast period due to its cost-effectiveness as compared to fresh non-donor and less-invasive nature of the procedure.

Q7. In in vitro fertilization market, which region is expected to be the largest in next 5 years?

Answer: APAC will witness the highest growth over the forecast period due to large number of population base in economies like China and India, growing awareness of IVF treatment, and rising number of infertile people in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the in vitro fertilization market by product (capital equipment, culture media, and disposable devices), type (fresh non-donors, frozen non-donors, fresh donors, and frozen donors), end use industry (fertility clinics and hospitals & others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global In Vitro Fertilization Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global In Vitro Fertilization Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global In Vitro Fertilization Market by Product
    • 3.3.1: Capital Equipment
    • 3.3.2: Culture Media
    • 3.3.3: Disposable Devices
  • 3.4: Global In Vitro Fertilization Market by Type
    • 3.4.1: Fresh Non-Donors
    • 3.4.2: Frozen Non-Donors
    • 3.4.3: Fresh Donors
    • 3.4.4: Frozen Donors
  • 3.5: Global In Vitro Fertilization Market by End Use Industry
    • 3.5.1: Fertility Clinics
    • 3.5.2: Hospitals & others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global In Vitro Fertilization Market by Region
  • 4.2: North American In Vitro Fertilization Market
    • 4.2.1: North American In Vitro Fertilization Market by Type: Fresh Non-Donors, Frozen Non-Donors, Fresh Donors, and Frozen Donors
    • 4.2.2: North American In Vitro Fertilization Market by End Use Industry: Fertility Clinics and Hospitals & others
  • 4.3: European In Vitro Fertilization Market
    • 4.3.1: European In Vitro Fertilization Market by Type: Fresh Non-Donors, Frozen Non-Donors, Fresh Donors, and Frozen Donors
    • 4.3.2: European In Vitro Fertilization Market by End Use Industry: Fertility Clinics and Hospitals & others
  • 4.4: APAC In Vitro Fertilization Market
    • 4.4.1: APAC In Vitro Fertilization Market by Type: Fresh Non-Donors, Frozen Non-Donors, Fresh Donors, and Frozen Donors
    • 4.4.2: APAC In Vitro Fertilization Market by End Use Industry: Fertility Clinics and Hospitals & others
  • 4.5: ROW In Vitro Fertilization Market
    • 4.5.1: ROW In Vitro Fertilization Market by Type: Fresh Non-Donors, Frozen Non-Donors, Fresh Donors, and Frozen Donors
    • 4.5.2: ROW In Vitro Fertilization Market by End Use Industry: Fertility Clinics and Hospitals & others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis
  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global In Vitro Fertilization Market by Product
    • 6.1.2: Growth Opportunities for the Global In Vitro Fertilization Market by Type
    • 6.1.3: Growth Opportunities for the Global In Vitro Fertilization Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global In Vitro Fertilization Market by Region
  • 6.2: Emerging Trends in the Global In Vitro Fertilization Market
  • 6.3: Strategic Analysis
    • 6.3.2: Capacity Expansion of the Global In Vitro Fertilization Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global In Vitro Fertilization Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: CooperSurgical
  • 7.2: Vitrolife
  • 7.3: Cook Medical
  • 7.4: Irvine Scientific
  • 7.5: Thermo Fisher Scientific
  • 7.6: EMD Sereno
  • 7.7: Genea Limited
  • 7.8: Esco Micro
  • 7.9: IVFtech
  • 7.10: The Baker Company